companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories














  • Prolia: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to treat osteoporosis in postmenopausal women at high risk for fracture, to treat glucocorticoid-induced osteoporosis, and to increase bone mass in men and women receiving certain treatments
  • Denosumab (subcutaneous route) - Mayo Clinic
    It is used to prevent bone problems in patients with multiple myeloma and bone metastases (cancer that has spread) from tumors Denosumab is also used to treat giant cell tumor of the bone that cannot be removed by surgery
  • Prolia Injection (Denosumab): Uses Side Effects
    What is this medication? DENOSUMAB (den oh sue mab) slows bone breakdown Prolia is used to treat osteoporosis in women after menopause and in men, and in people who are taking corticosteroids for 6 months or more
  • Prolia (Prolia, Jubbonti, Wyost): Uses, Side Effects . . . - WebMD
    Denosumab (Prolia, Jubbonti, Wyost) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to breakage Denosumab may be prescribed for
  • Denosumab: Bone Loss Uses, Side Effects, Warnings, Dosage
    Denosumab is a lab-made human monoclonal immunoglobulin G2 (IgG2) antibody medication used to reduce bone loss in patients at high risk for bone fractures due to postmenopausal osteoporosis, cancers or other conditions
  • Denosumab (Xgeva®, Prolia®) - Macmillan Cancer Support
    Denosumab (XGEVA®, Prolia®) is used to strengthen and protect the bones from the effect of cancer or cancer treatment It belongs to a group of targeted therapy drugs known as monoclonal antibodies
  • Denosumab - NCI - National Cancer Institute
    giant cell tumor of the bone that cannot be removed by surgery It is used in adults and in adolescents whose bones have finished growing These uses are approved for the Xgeva brand of denosumab Denosumab is approved to prevent: broken bones and other bone problems caused by multiple myeloma or by solid tumors that have spread to bone




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer